4.7 Article

Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Association of serum calcium and phosphorus with measures of left ventricular structure and function: The ARIC study

Kripa Poudel et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)

Article Urology & Nephrology

Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD

Shilpa Sharma et al.

KIDNEY INTERNATIONAL REPORTS (2019)

Article Urology & Nephrology

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT

Charles Ginsberg et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Article Peripheral Vascular Disease

Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study

Amber L. Fyfe-Johnson et al.

JOURNAL OF HYPERTENSION (2016)

Article Urology & Nephrology

Residual Kidney Function Decline and Mortality in Incident Hemodialysis. Patients

Yoshitsugu Obi et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Review Urology & Nephrology

Preservation of residual kidney function in hemodialysis patients: reviving an old concept

Anna T. Mathew et al.

KIDNEY INTERNATIONAL (2016)

Article Urology & Nephrology

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis

Julia J. Scialla et al.

AMERICAN JOURNAL OF NEPHROLOGY (2015)

Review Urology & Nephrology

Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease

Myles Wolf et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)

Article Medicine, Research & Experimental

FGF23 regulates renal sodium handling and blood pressure

Olena Andrukhova et al.

EMBO MOLECULAR MEDICINE (2014)

Article Medicine, General & Internal

Elevated E/E' Predicts Cardiovascular Events in Hemodialysis Patients with Preserved Systolic Function

Yuko Iwabuchi et al.

INTERNAL MEDICINE (2012)

Article Cardiac & Cardiovascular Systems

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals CHS (Cardiovascular Health Study)

Joachim H. Ix et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Review Urology & Nephrology

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

Myles Wolf

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Review Urology & Nephrology

Clinical relevance of FGF-23 in chronic kidney disease

Sarah Seiler et al.

KIDNEY INTERNATIONAL (2009)

Article Endocrinology & Metabolism

Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata

Hisashi Masugata et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2008)

Article Medicine, General & Internal

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Orlando M. Gutierrez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Transplantation

Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality

GM London et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)

Article Medicine, General & Internal

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

KB Jonsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)